Mismatch repair deficiency testing in clinical practice
- PMID: 26895074
- DOI: 10.1586/14737159.2016.1156533
Mismatch repair deficiency testing in clinical practice
Abstract
Lynch syndrome, an autosomal dominant inherited disorder, is caused by inactivating mutations involving DNA mismatch repair (MMR) genes. This leads to profound genetic instability, including microsatellite instability (MSI) and increased risk for cancer development, particularly colon and endometrial malignancies. Clinical testing of tumor tissues for the presence of MMR gene deficiency is standard practice in clinical oncology, with immunohistochemistry and PCR-based microsatellite instability analysis used as screening tests to identify potential Lynch syndrome families. The ultimate diagnosis of Lynch syndrome requires documentation of mutation within one of the four MMR genes (MLH1, PMS2, MSH2 and MSH6) or EPCAM, currently achieved by comprehensive sequencing analysis of germline DNA. In this review, the genetic basis of Lynch syndrome, methodologies of MMR deficiency testing, and current diagnostic algorithms in the clinical management of Lynch syndrome, are discussed.
Keywords: Colorectal and Endometrial cancers; DNA mismatch repair gene; Lynch syndrome; Microsatellite instability.
Similar articles
-
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.J Clin Oncol. 2015 Dec 20;33(36):4301-8. doi: 10.1200/JCO.2015.63.9518. Epub 2015 Nov 9. J Clin Oncol. 2015. PMID: 26552419 Free PMC article.
-
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.Gastroenterology. 2014 Dec;147(6):1308-1316.e1. doi: 10.1053/j.gastro.2014.08.041. Epub 2014 Sep 3. Gastroenterology. 2014. PMID: 25194673 Free PMC article.
-
Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.Oncol Rep. 2016 Nov;36(5):2823-2835. doi: 10.3892/or.2016.5060. Epub 2016 Sep 1. Oncol Rep. 2016. PMID: 27601186
-
Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.Int J Clin Oncol. 2019 Sep;24(9):999-1011. doi: 10.1007/s10147-019-01494-y. Epub 2019 Jul 4. Int J Clin Oncol. 2019. PMID: 31273487 Review.
-
Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.Gene. 2016 Sep 10;589(2):127-32. doi: 10.1016/j.gene.2015.06.078. Epub 2015 Jul 2. Gene. 2016. PMID: 26143115 Review.
Cited by
-
Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis.Front Oncol. 2024 Jun 18;14:1396869. doi: 10.3389/fonc.2024.1396869. eCollection 2024. Front Oncol. 2024. PMID: 38957326 Free PMC article.
-
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer.Int J Mol Sci. 2020 Feb 21;21(4):1461. doi: 10.3390/ijms21041461. Int J Mol Sci. 2020. PMID: 32098071 Free PMC article. Clinical Trial.
-
Impact of tissue-agnostic approvals for patients with gastrointestinal malignancies.Trends Cancer. 2023 Mar;9(3):237-249. doi: 10.1016/j.trecan.2022.11.003. Epub 2022 Dec 7. Trends Cancer. 2023. PMID: 36494311 Free PMC article. Review.
-
Molecular Diagnostics in Clinical Oncology.Front Mol Biosci. 2018 Aug 27;5:76. doi: 10.3389/fmolb.2018.00076. eCollection 2018. Front Mol Biosci. 2018. PMID: 30211169 Free PMC article. Review.
-
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer.Sci Rep. 2021 Jun 18;11(1):12880. doi: 10.1038/s41598-021-91974-x. Sci Rep. 2021. PMID: 34145315 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
